243 filings
Page 2 of 13
424B5
vn6ttdaasru
11 Apr 24
Prospectus supplement for primary offering
1:30pm
424B5
aa2vfx5e81vkc5s
9 Apr 24
Prospectus supplement for primary offering
9:15am
8-K
mk8 hxz6rz0rq62bsyr4
5 Apr 24
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
8:30am
8-K
e5orn
4 Apr 24
Material Modifications to Rights of Security Holders
5:01pm
8-K
vbpegk5
1 Apr 24
Regulation FD Disclosure
9:36am
8-K
45cglup9
26 Mar 24
Regulation FD Disclosure
8:05am
S-8
hpflb
25 Mar 24
Registration of securities for employees
4:33pm
8-K
it2o35
19 Mar 24
Entry into a Material Definitive Agreement
8:41pm
424B5
tde1dx4lr4o7fw 73yt
19 Mar 24
Prospectus supplement for primary offering
8:40pm
8-K
nb2b2i7l h175
15 Mar 24
Entry into a Material Definitive Agreement
9:14am
8-K
w8u51hat
8 Mar 24
Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update
8:38am
8-K
wxewk1r0ycocu3
4 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
r20744grb4pp9el6gv0u
1 Mar 24
Entry into a Material Definitive Agreement
9:21am
PRER14A
p1i2 3hgu
23 Feb 24
Preliminary revised proxy
4:09pm
8-K
u04 7scrj4w56jazpyh2
14 Feb 24
Entry into a Material Definitive Agreement
9:03am
D
1hdmhyo3hcfbqn3 fin
2 Feb 24
$1.40 mm in debt, sold $400.00 k, 1 investor
5:03pm
8-K
ox3sbd8aos i2u4kgtgu
1 Feb 24
Termination of a Material Definitive Agreement
4:40pm